Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.23%
#2 PulseChain PulseChain +58.72%
#3 Ontology Gas Ontology Gas +43.64%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.65%
#5 BOOK OF MEME BOOK OF MEME +32.21%
#6 ConstitutionDAO ConstitutionDAO +31.98%
#7 Neiro Neiro +27.31%
#8 Unit Pump Unit Pump +24.92%
#9 Pump.fun Pump.fun +24.92%
#10 Collect on Fanable Collect on Fanable +24.89%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Alps Group Inc Alps Group Inc

Alps Group Inc

ALPS
Rank in Stocks #26007
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a... Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Share Price
$0.2743
Market Cap
$45.64M
Change (1 day)
1.59%
Change (1 year)
-
Country
MY
Trade Alps Group Inc (ALPS)

Category

Healthcare
Revenue for Alps Group Inc (ALPS)
Revenue in Aug 2026 TTM: 0
According to Alps Group Inc latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Alps Group Inc from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH